• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors.新型强效选择性炔基噻唑衍生的PI3Kγ抑制剂系列的发现
ACS Med Chem Lett. 2020 Dec 18;12(1):129-135. doi: 10.1021/acsmedchemlett.0c00573. eCollection 2021 Jan 14.
2
Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.用于治疗炎症和自身免疫性疾病的磷酸肌醇3-激酶γ(PI3Kγ)抑制剂。
Recent Pat Inflamm Allergy Drug Discov. 2010 Jan;4(1):1-15. doi: 10.2174/187221310789895603.
3
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors.基于7-氮杂吲哚异吲哚啉酮的强效选择性PI3Kγ抑制剂的发现
ACS Med Chem Lett. 2020 Sep 24;11(11):2244-2252. doi: 10.1021/acsmedchemlett.0c00387. eCollection 2020 Nov 12.
4
Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.呋喃-2-基亚甲基噻唑烷二酮类化合物作为新型、强效且选择性的磷酸肌醇3-激酶γ抑制剂
J Med Chem. 2006 Jun 29;49(13):3857-71. doi: 10.1021/jm0601598.
5
Development of PI3Kγ selective inhibitors: the strategies and application.PI3Kγ 选择性抑制剂的研发:策略与应用。
Acta Pharmacol Sin. 2024 Feb;45(2):238-247. doi: 10.1038/s41401-023-01166-8. Epub 2023 Oct 6.
6
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS).新型口服生物利用度、可穿透中枢神经系统、同工型选择性磷酸肌醇 3-激酶 γ(PI3Kγ)抑制剂的设计与合成及其在多发性硬化症(MS)治疗中的应用潜力。
J Med Chem. 2018 Jun 28;61(12):5245-5256. doi: 10.1021/acs.jmedchem.8b00085. Epub 2018 Jun 14.
7
Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.靶向磷酸肌醇3-激酶γ以对抗炎症及其他作用。
Thromb Haemost. 2008 Feb;99(2):279-85. doi: 10.1160/TH07-10-0632.
8
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).设计、合成及吡唑并嘧啶酰胺类磷酸肌醇 3-激酶 γ(PI3Kγ)抑制剂的构效关系优化。
J Med Chem. 2022 Jan 27;65(2):1418-1444. doi: 10.1021/acs.jmedchem.1c01153. Epub 2021 Oct 21.
9
Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.PI3Kγ 和 δ 抑制剂在炎症和自身免疫性疾病中的研究进展。
J Med Chem. 2019 May 23;62(10):4783-4814. doi: 10.1021/acs.jmedchem.8b01298. Epub 2018 Dec 24.
10
Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.磷脂酰肌醇 3 激酶-γ在甲型 H1N1 流感感染期间平衡抗病毒和炎症反应:从小鼠模型到患者的遗传关联。
Front Immunol. 2018 May 15;9:975. doi: 10.3389/fimmu.2018.00975. eCollection 2018.

引用本文的文献

1
Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids.用芪类化合物的新型衍生物对磷脂酰肌醇3-激酶-γ进行结构建模。
Biochem Biophys Rep. 2024 Nov 18;40:101861. doi: 10.1016/j.bbrep.2024.101861. eCollection 2024 Dec.
2
Development of PI3Kγ selective inhibitors: the strategies and application.PI3Kγ 选择性抑制剂的研发:策略与应用。
Acta Pharmacol Sin. 2024 Feb;45(2):238-247. doi: 10.1038/s41401-023-01166-8. Epub 2023 Oct 6.
3
Macrophage polarization in diabetic wound healing.糖尿病伤口愈合中的巨噬细胞极化
Burns Trauma. 2022 Dec 29;10:tkac051. doi: 10.1093/burnst/tkac051. eCollection 2022.
4
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases.磷脂酰肌醇3激酶γ(PI3Kγ)在呼吸系统疾病中的作用。
Cell Stress. 2021 Mar 8;5(4):40-51. doi: 10.15698/cst2021.04.246.

本文引用的文献

1
Acetylene Group, Friend or Foe in Medicinal Chemistry.乙炔基,医药化学中的友军还是敌军?
J Med Chem. 2020 Jun 11;63(11):5625-5663. doi: 10.1021/acs.jmedchem.9b01617. Epub 2020 Feb 19.
2
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS).新型口服生物利用度、可穿透中枢神经系统、同工型选择性磷酸肌醇 3-激酶 γ(PI3Kγ)抑制剂的设计与合成及其在多发性硬化症(MS)治疗中的应用潜力。
J Med Chem. 2018 Jun 28;61(12):5245-5256. doi: 10.1021/acs.jmedchem.8b00085. Epub 2018 Jun 14.
3
Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts.在细胞或生理环境中,化合物效力增加的原因和意义。
J Med Chem. 2018 Mar 8;61(5):1767-1773. doi: 10.1021/acs.jmedchem.7b00762. Epub 2017 Aug 18.
4
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.发现一种选择性磷酸肌醇-3-激酶(PI3K)-γ抑制剂(IPI-549)作为免疫肿瘤学临床候选药物。
ACS Med Chem Lett. 2016 Jul 22;7(9):862-7. doi: 10.1021/acsmedchemlett.6b00238. eCollection 2016 Sep 8.
5
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ.发现高度同工型选择性噻唑并哌啶类磷酸肌醇 3-激酶 γ 抑制剂。
J Med Chem. 2015 Jul 23;58(14):5684-8. doi: 10.1021/acs.jmedchem.5b00498. Epub 2015 Jul 6.
6
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.一类苯并噻唑类磷酸肌醇 3-激酶 γ 抑制剂的结构对异构体选择性的基础。
J Med Chem. 2015 Jan 8;58(1):517-21. doi: 10.1021/jm500362j. Epub 2014 May 2.
7
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.PI3K抑制剂在自身免疫性风湿病中的治疗潜力
Open Rheumatol J. 2012;6:245-58. doi: 10.2174/1874312901206010245. Epub 2012 Sep 7.
8
Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.超越规则:中枢神经系统多参数优化 (CNS MPO) 方法的开发,以实现类似药物特性的一致性。
ACS Chem Neurosci. 2010 Jun 16;1(6):435-49. doi: 10.1021/cn100008c. Epub 2010 Mar 25.
9
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.Caco-2 和 MDCK 细胞系中的药物渗透和转运体测定。
Future Med Chem. 2011 Dec;3(16):2063-77. doi: 10.4155/fmc.11.149.
10
The emerging mechanisms of isoform-specific PI3K signalling.新兴的同工型特异性 PI3K 信号转导机制。
Nat Rev Mol Cell Biol. 2010 May;11(5):329-41. doi: 10.1038/nrm2882. Epub 2010 Apr 9.

新型强效选择性炔基噻唑衍生的PI3Kγ抑制剂系列的发现

Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors.

作者信息

Bandarage Upul K, Aronov Alex M, Cao Jingrong, Come Jon H, Cottrell Kevin M, Davies Robert J, Giroux Simon, Jacobs Marc, Mahajan Sudipta, Messersmith David, Moody Cameron S, Swett Rebecca, Xu Jinwang

机构信息

Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210, United States.

出版信息

ACS Med Chem Lett. 2020 Dec 18;12(1):129-135. doi: 10.1021/acsmedchemlett.0c00573. eCollection 2021 Jan 14.

DOI:10.1021/acsmedchemlett.0c00573
PMID:33488974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7812679/
Abstract

Phosphoinositide 3-kinases (PI3Ks) are a family of enzymes that control a wide variety of cellular functions such as cell growth, proliferation, differentiation, motility, survival, and intracellular trafficking. PI3Kγ plays a critical role in mediating leukocyte chemotaxis as well as mast cell degranulation, making it a potentially interesting target for autoimmune and inflammatory diseases. We previously disclosed a novel series of PI3Kγ inhibitors derived from a benzothiazole core. The truncation of the benzothiazole core led to the discovery of a structurally diverse alkynyl thiazole series which displayed high PI3Kγ potency and subtype selectivity. Further medicinal chemistry optimization of the alkynyl thiazole series led to identification of compounds such as and , highly potent, subtype selective, and CNS penetrant PI3Kγ inhibitors. Compound showed robust inhibition of PI3Kγ mediated neutrophil migration .

摘要

磷脂酰肌醇3-激酶(PI3Ks)是一类酶,可控制多种细胞功能,如细胞生长、增殖、分化、运动、存活和细胞内运输。PI3Kγ在介导白细胞趋化性以及肥大细胞脱颗粒中起关键作用,使其成为自身免疫性疾病和炎症性疾病潜在的有趣靶点。我们之前公开了一系列源自苯并噻唑核心的新型PI3Kγ抑制剂。苯并噻唑核心的截短导致发现了结构多样的炔基噻唑系列,该系列显示出高PI3Kγ效力和亚型选择性。对炔基噻唑系列进行进一步的药物化学优化,得到了如化合物 和 等高效、亚型选择性且具有中枢神经系统渗透性的PI3Kγ抑制剂。化合物 对PI3Kγ介导的中性粒细胞迁移表现出强烈抑制作用。